Table 4.
|
All institutions (N = 4,946 patients) |
||
---|---|---|---|
β | p-value | CI 95% | |
Year |
11.91 |
<10-4 |
[5.90; 17.93] |
Interactions |
|
|
|
Year*public |
2.08 |
0.93 |
[-42.92; 47.08] |
Year*hematologist or oncologist |
6.12 |
0.02 |
[0.98; 11.27] |
Year*research |
-2.59 |
0.13 |
[-5.94; 0.75] |
Year*bone aspiration |
-8.78 |
<10-4 |
[-12.89; -4.66] |
Year*Europe |
0.00 (ref) |
|
|
Year*SE Asia |
3.04 |
0.34 |
[-3.24; 9.33] |
Year*East Africa |
-0.59 |
0.78 |
[-4.86;3.67] |
Year*West Africa |
-11.49 |
<10-4 |
[-15.53; -7.45] |
Year*Pacific/America | -14.66 | <10-4 | [-19.54; -9.77] |
Results in bold are statistically significant at the 5% level.